Swissray to divest Empower as part of restructuring effort

Article

Swissray to divest Empower as part of restructuring effortDigital radiography developer Swissray International last month announced that it has signed a letter of intent to sell its Swissray Empower U.S. film and x-ray accessories division, a

Swissray to divest Empower as part of restructuring effort

Digital radiography developer Swissray International last month announced that it has signed a letter of intent to sell its Swissray Empower U.S. film and x-ray accessories division, a business it acquired less than a year ago. Swissray said it was making the move as part of a corporate reorganization designed to focus the company on digital imaging.

Swissray acquired Empower in April 1997 as part of the company's aggressive effort to offer a wide range of products and services to customers. The decision to divest Empower may be a sign that the company's plan may have been a bit ambitious, however. Swissray also has multivendor service and PACS subsidiaries, in addition to its conventional and digital x-ray manufacturing business (PNN 2/98).

Swissray will sell Empower to distributor E.M. Parker, based in Wilmington, MA. Terms of the transaction are still being negotiated, with a completion date expected during the current fiscal year, according to Swissray of New York City.

The company's board of directors has also announced that it has decided to restructure its senior management as part of a plan to grow Swissray beyond a developmental-stage company, said Ruedi Laupper, chairman. A search is under way for a new CEO and CFO. In the meantime, primary management responsibility will be held by a newly formed executive committee of the board of directors, consisting of Akbar Seddigh, Daniel Wuersch, and Dr. Erwin Zimmerli. Laupper, who previously also held the titles of president and CEO, retains primary responsibility for day-to-day operations.

The vendor is also reviewing its strategic focus, and is preparing a long-term business and financial plan so that the company can raise capital to successfully implement its strategy over the next two years. In an earlier release, Swissray disclosed that it planned to enter into immediate negotiations with a group of investors to finance the firm's short-term and medium-term capital needs.

In other Swissray news, the company has sold another AddOn-Multi-System to Dutchess Radiology Associates, of Poughkeepsie, NY. Financial terms of the sale were not disclosed.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.